Skip to main content
Top
Published in: BMC Women's Health 1/2016

Open Access 01-12-2016 | Research article

Vision-related quality of life and psychological status in Chinese women with Sjogren’s syndrome dry eye: a case-control study

Authors: Yuqiu Zhang, Tong Lin, Alice Jiang, Naiqing Zhao, Lan Gong

Published in: BMC Women's Health | Issue 1/2016

Login to get access

Abstract

Background

Sjogren’s syndrome dry eye (SSDE) mainly affects middle-aged women and can negatively affect women’s psychological and social functioning. However, little is known about the correlation between vision-related quality of life (VR-QoL) and psychological status for women with SSDE. We therefore examined VR-QoL and psychological status in two groups of Chinese women: an SSDE group and a non-SSDE group. We also explored the associations between VR-QoL scores, sociodemographic measures, ophthalmologic parameters, and psychological status in women with SSDE.

Methods

The case-control study recruited 30 female outpatients with SSDE and 30 without SSDE from the Eye and Ear, Nose, and Throat (ENT) Hospital of Fudan University. Demographic and ophthalmologic data were collected from all participants. Ophthalmologic examinations included best-corrected visual acuity (BCVA), corneal fluorescein staining (CFS), tear break-up time (TBUT) and Schirmer test. Data collected using the National Eye Institute’s Visual Function Questionnaire (NEI-VFQ) and Ocular Surface Disease Index (OSDI) survey instruments were analyzed to identify potential differences in VR-QoL between the SSDE group and the non-SSDE group. We also used the Zung Self-Rating Anxiety and Self-Rating Depression Scales (SAS and SDS) to determine psychological status in both groups.

Results

The SSDE group scored significantly lower than the non-SSDE group on the NEI-VFQ subscales of general health, general vision, and long-distance vision activities (all p < 0.05). The SSDE group achieved a significantly higher ocular symptoms score compared with the control group (p = 0.0256). The SAS and SDS scores of the SSDE group were significantly higher than the non-SSDE group (p = 0.0072 and 0.0162, respectively). The prevalence of anxiety and depression in the SSDE group was significantly higher than the non-SSDE group (p = 0.0240 and 0.0200, respectively). Nine of twelve NEI-VFQ subscales were negatively correlated with SAS/SDS scores (all p values were <0.05). The exceptions were social function, color vision and peripheral vision. The composite OSDI score and its three subscale scores for the women in the SSDE group were all positively correlated with overall SAS/SDS scores (all p values were <0.05).

Conclusions

Both VR-QoL and psychological status were significantly worse in SSDE group than in the non-SSDE group. The VR-QoL of women with SSDE had a negative correlation with their anxiety and depression levels.
Literature
2.
go back to reference Bjerrum KB. Keratoconjunctivitis sicca and primary Sjogren’s syndrome in a Danish population aged 30–60 years. Acta Ophthalmol Scand. 1997;75:281–6.CrossRefPubMed Bjerrum KB. Keratoconjunctivitis sicca and primary Sjogren’s syndrome in a Danish population aged 30–60 years. Acta Ophthalmol Scand. 1997;75:281–6.CrossRefPubMed
3.
go back to reference Tincani A, Andreoli L, Cavazzana I, Doria A, Favero M, Fenini MG, Franceschini F, Lojacono A, Nascimbeni G, Santoro A, Semeraro F, Toniati P, Shoenfeld Y. Novel aspects of Sjogren’s syndrome in 2012. BMC Med. 2013;11:93.CrossRefPubMedPubMedCentral Tincani A, Andreoli L, Cavazzana I, Doria A, Favero M, Fenini MG, Franceschini F, Lojacono A, Nascimbeni G, Santoro A, Semeraro F, Toniati P, Shoenfeld Y. Novel aspects of Sjogren’s syndrome in 2012. BMC Med. 2013;11:93.CrossRefPubMedPubMedCentral
4.
go back to reference Pedersen AM, Nauntofte B. Primary Sjogren’s syndrome: oral aspects on pathogenesis, diagnostic criteria, clinical features and approaches for therapy. Expert Opin Pharmacother. 2001;2:1415–36.CrossRefPubMed Pedersen AM, Nauntofte B. Primary Sjogren’s syndrome: oral aspects on pathogenesis, diagnostic criteria, clinical features and approaches for therapy. Expert Opin Pharmacother. 2001;2:1415–36.CrossRefPubMed
5.
go back to reference Meijer JM, Meiners PM, Huddleston Slater JJ, Spijkervet FK, Kallenberg CG, Vissink A, Bootsma H. Health-related quality of life, employment and disability in patients with Sjogren’s syndrome. Rheumatology (Oxford). 2009;48:1077–82.CrossRef Meijer JM, Meiners PM, Huddleston Slater JJ, Spijkervet FK, Kallenberg CG, Vissink A, Bootsma H. Health-related quality of life, employment and disability in patients with Sjogren’s syndrome. Rheumatology (Oxford). 2009;48:1077–82.CrossRef
6.
go back to reference Bjerrum K, Prause JU. Primary Sjogren’s syndrome: a subjective description of the disease. Clin Exp Rheumatol. 1990;8:283–8.PubMed Bjerrum K, Prause JU. Primary Sjogren’s syndrome: a subjective description of the disease. Clin Exp Rheumatol. 1990;8:283–8.PubMed
7.
go back to reference Inal V, Kitapcioglu G, Karabulut G, Keser G, Kabasakal Y. Evaluation of quality of life in relation to anxiety and depression in primary Sjogren’s syndrome. Mod Rheumatol. 2010;20:588–97.CrossRefPubMed Inal V, Kitapcioglu G, Karabulut G, Keser G, Kabasakal Y. Evaluation of quality of life in relation to anxiety and depression in primary Sjogren’s syndrome. Mod Rheumatol. 2010;20:588–97.CrossRefPubMed
8.
go back to reference Peri Y, Agmon-Levin N, Theodor E, Shoenfeld Y. Sjogren’s syndrome, the old and the new. Best Pract Res Clin Rheumatol. 2012;26:105–17.CrossRefPubMed Peri Y, Agmon-Levin N, Theodor E, Shoenfeld Y. Sjogren’s syndrome, the old and the new. Best Pract Res Clin Rheumatol. 2012;26:105–17.CrossRefPubMed
9.
go back to reference Mavragani CP, Nezos A, Moutsopoulos HM. New advances in the classification, pathogenesis and treatment of Sjogren’s syndrome. Curr Opin Rheumatol. 2013;25:623–9.CrossRefPubMed Mavragani CP, Nezos A, Moutsopoulos HM. New advances in the classification, pathogenesis and treatment of Sjogren’s syndrome. Curr Opin Rheumatol. 2013;25:623–9.CrossRefPubMed
10.
go back to reference Arakaki R, Eguchi H, Yamada A, Kudo Y, Iwasa A, Enkhmaa T, Hotta F, Mitamura-Aizawa S, Mitamura Y, Hayashi Y, Ishimaru N. Anti-inflammatory effects of rebamipide eyedrop administration on ocular lesions in a murine model of primary Sjögren’s syndrome. PLoS One. 2014;9(5):e98390.CrossRefPubMedPubMedCentral Arakaki R, Eguchi H, Yamada A, Kudo Y, Iwasa A, Enkhmaa T, Hotta F, Mitamura-Aizawa S, Mitamura Y, Hayashi Y, Ishimaru N. Anti-inflammatory effects of rebamipide eyedrop administration on ocular lesions in a murine model of primary Sjögren’s syndrome. PLoS One. 2014;9(5):e98390.CrossRefPubMedPubMedCentral
11.
go back to reference Pflugfelder SC, Tseng SC, Sanabria O, Kell H, Garcia CG, Felix C, Feuer W, Reis BL. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea. 1998;17:38–56.CrossRefPubMed Pflugfelder SC, Tseng SC, Sanabria O, Kell H, Garcia CG, Felix C, Feuer W, Reis BL. Evaluation of subjective assessments and objective diagnostic tests for diagnosing tear-film disorders known to cause ocular irritation. Cornea. 1998;17:38–56.CrossRefPubMed
12.
go back to reference Rivas L, Murube J, Shalaby O, Oroza MA, Sanz AI. Impression cytology contribution to differential diagnosis of Sjogren syndrome in the ophthalmological clinic. Arch Soc Esp Ophthalmol. 2002;77:63–72. Rivas L, Murube J, Shalaby O, Oroza MA, Sanz AI. Impression cytology contribution to differential diagnosis of Sjogren syndrome in the ophthalmological clinic. Arch Soc Esp Ophthalmol. 2002;77:63–72.
13.
go back to reference Nelson JD, Helms H, Fiscella R. A new look at dry eye disease and its treatment. Adv Ther. 2000;17:84–93.CrossRefPubMed Nelson JD, Helms H, Fiscella R. A new look at dry eye disease and its treatment. Adv Ther. 2000;17:84–93.CrossRefPubMed
14.
go back to reference Li M, Gong L, Chapin WJ, Zhu M. Assessment of vision-related quality of life in dry eye patients. Invest Ophthalmol Vis Sci. 2012;53(9):5722–7.CrossRefPubMed Li M, Gong L, Chapin WJ, Zhu M. Assessment of vision-related quality of life in dry eye patients. Invest Ophthalmol Vis Sci. 2012;53(9):5722–7.CrossRefPubMed
15.
go back to reference Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjögren’s Syndrome. Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8.CrossRefPubMedPubMedCentral Vitali C, Bombardieri S, Jonsson R, Moutsopoulos HM, Alexander EL, Carsons SE, Daniels TE, Fox PC, Fox RI, Kassan SS, Pillemer SR, Talal N, Weisman MH, European Study Group on Classification Criteria for Sjögren’s Syndrome. Classification criteria for Sjogren’s syndrome: a revised version of the European criteria proposed by the American-European Consensus Group. Ann Rheum Dis. 2002;61:554–8.CrossRefPubMedPubMedCentral
16.
go back to reference Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050–8.CrossRefPubMed Mangione CM, Lee PP, Gutierrez PR, Spritzer K, Berry S, Hays RD. National Eye Institute Visual Function Questionnaire Field Test Investigators. Development of the 25-item National Eye Institute Visual Function Questionnaire. Arch Ophthalmol. 2001;119:1050–8.CrossRefPubMed
17.
go back to reference Le Q, Ge L, Li M, Wu L, Xu J, Hong J, Gong L. Comparison on the vision-related quality of life between outpatients and general population with dry eye syndrome. Acta Ophthalmol. 2014;92(2):e124–32.CrossRefPubMed Le Q, Ge L, Li M, Wu L, Xu J, Hong J, Gong L. Comparison on the vision-related quality of life between outpatients and general population with dry eye syndrome. Acta Ophthalmol. 2014;92(2):e124–32.CrossRefPubMed
18.
go back to reference Chan CW, Wong D, Lam CL, McGhee S, Lai WW. Development of a Chinese version of the National Eye Institute Visual Function Questionnaire (CHI-VFQ-25) as a tool to study patients with eye diseases in Hong Kong. Br J Ophthalmol. 2009;93:1431–6.CrossRefPubMed Chan CW, Wong D, Lam CL, McGhee S, Lai WW. Development of a Chinese version of the National Eye Institute Visual Function Questionnaire (CHI-VFQ-25) as a tool to study patients with eye diseases in Hong Kong. Br J Ophthalmol. 2009;93:1431–6.CrossRefPubMed
19.
go back to reference Yildiz EH, Cohen EJ, Virdi AS, Hammersmith KM, Laibson PR, Rapuano CJ. Quality of life in keratoconus patients after penetrating keratoplasty. Am J Ophthalmol. 2010;149:416–22.CrossRefPubMed Yildiz EH, Cohen EJ, Virdi AS, Hammersmith KM, Laibson PR, Rapuano CJ. Quality of life in keratoconus patients after penetrating keratoplasty. Am J Ophthalmol. 2010;149:416–22.CrossRefPubMed
20.
go back to reference Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118:615–21.CrossRefPubMed Schiffman RM, Christianson MD, Jacobsen G, Hirsch JD, Reis BL. Reliability and validity of the Ocular Surface Disease Index. Arch Ophthalmol. 2000;118:615–21.CrossRefPubMed
23.
go back to reference Balasubramaniam M, Telles S, Doraiswamy PM. Yoga on our minds: a systematic review of yoga for neuropsychiatric disorders. Front Psych. 2012;3:117. Balasubramaniam M, Telles S, Doraiswamy PM. Yoga on our minds: a systematic review of yoga for neuropsychiatric disorders. Front Psych. 2012;3:117.
24.
go back to reference Mariette X. Current and potential treatments for primary Sjogren’s syndrome. Joint Bone Spine. 2002;69:363–6.CrossRefPubMed Mariette X. Current and potential treatments for primary Sjogren’s syndrome. Joint Bone Spine. 2002;69:363–6.CrossRefPubMed
25.
go back to reference Liew MS, Zhang M, Kim E, Akpek EK. Prevalence and predictors of Sjogren’s syndrome in a prospective cohort of patients with aqueous-deficient dry eye. Br J Ophthalmol. 2012;96(12):1498–503.CrossRefPubMed Liew MS, Zhang M, Kim E, Akpek EK. Prevalence and predictors of Sjogren’s syndrome in a prospective cohort of patients with aqueous-deficient dry eye. Br J Ophthalmol. 2012;96(12):1498–503.CrossRefPubMed
26.
go back to reference Brignole F, Pisella PJ, Goldschild M, De Saint Jean M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci. 2000;41:1356–63.PubMed Brignole F, Pisella PJ, Goldschild M, De Saint Jean M, Goguel A, Baudouin C. Flow cytometric analysis of inflammatory markers in conjunctival epithelial cells of patients with dry eyes. Invest Ophthalmol Vis Sci. 2000;41:1356–63.PubMed
27.
go back to reference Kunert KS, Tisdale AS, Gipson IK. Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine. Arch Ophthalmol. 2002;120:330–7.CrossRefPubMed Kunert KS, Tisdale AS, Gipson IK. Goblet cell numbers and epithelial proliferation in the conjunctiva of patients with dry eye syndrome treated with cyclosporine. Arch Ophthalmol. 2002;120:330–7.CrossRefPubMed
28.
go back to reference Kaido M, Matsumoto Y, Shigeno Y, Ishida R, Dogru M, Tsubota K. Corneal fluorescein staining correlates with visual function in dry eye patients. Invest Ophthalmol Vis Sci. 2011;52:9516–22.CrossRefPubMed Kaido M, Matsumoto Y, Shigeno Y, Ishida R, Dogru M, Tsubota K. Corneal fluorescein staining correlates with visual function in dry eye patients. Invest Ophthalmol Vis Sci. 2011;52:9516–22.CrossRefPubMed
29.
go back to reference Wang Y, Xu J, Sun X, Chu R, Zhuang H, He JC. Dynamic wavefront aberrations and visual acuity in normal and dry eyes. Clin Exp Optom. 2009;92:267–73.CrossRefPubMed Wang Y, Xu J, Sun X, Chu R, Zhuang H, He JC. Dynamic wavefront aberrations and visual acuity in normal and dry eyes. Clin Exp Optom. 2009;92:267–73.CrossRefPubMed
30.
go back to reference Ridder WH, Tomlinson A, Huang JF, Li J. Impaired visual performance in patients with dry eye. Ocul Surf. 2011;9:42–55.CrossRefPubMed Ridder WH, Tomlinson A, Huang JF, Li J. Impaired visual performance in patients with dry eye. Ocul Surf. 2011;9:42–55.CrossRefPubMed
31.
go back to reference Zhang Y, Potvin R, Gong L. A Study of the Short-Term Effect of Artificial Tears on Contrast Sensitivity in Patients with Sjogren’s Syndrome. Invest Ophthalmol Vis Sci. 2013;54:7977–82.CrossRefPubMed Zhang Y, Potvin R, Gong L. A Study of the Short-Term Effect of Artificial Tears on Contrast Sensitivity in Patients with Sjogren’s Syndrome. Invest Ophthalmol Vis Sci. 2013;54:7977–82.CrossRefPubMed
32.
go back to reference Li M, Gong L, Sun X, Chapin WJ. Anxiety and depression in patients with dry eye syndrome. Curr Eye Res. 2011;36(1):1–7.CrossRefPubMed Li M, Gong L, Sun X, Chapin WJ. Anxiety and depression in patients with dry eye syndrome. Curr Eye Res. 2011;36(1):1–7.CrossRefPubMed
33.
go back to reference Valtysdottir ST, Gudbjornsson B, Hallgren R, Hetta J. Psychological well-being in patients with primary Sjogren’s syndrome. Clin Exp Rheumatol. 2000;18:597–600.PubMed Valtysdottir ST, Gudbjornsson B, Hallgren R, Hetta J. Psychological well-being in patients with primary Sjogren’s syndrome. Clin Exp Rheumatol. 2000;18:597–600.PubMed
34.
go back to reference Stevenson HA, Jones ME, Rostron JL, Longman LP, Field EA. UK patients with primary Sjogren’s syndrome are at increased risk from clinical depression. Gerodontology. 2004;21:141–5.CrossRefPubMed Stevenson HA, Jones ME, Rostron JL, Longman LP, Field EA. UK patients with primary Sjogren’s syndrome are at increased risk from clinical depression. Gerodontology. 2004;21:141–5.CrossRefPubMed
35.
go back to reference Valtysdottir ST, Gudbjornsson B, Lindqvist U, Hallgren R, Hetta J. Anxiety and depression in patients with primary Sjogren’s syndrome. J Rheumatol. 2000;27:165–9.PubMed Valtysdottir ST, Gudbjornsson B, Lindqvist U, Hallgren R, Hetta J. Anxiety and depression in patients with primary Sjogren’s syndrome. J Rheumatol. 2000;27:165–9.PubMed
36.
go back to reference Segal B, Bowman SJ, Fox PC, Vivino FB, Murukutla N, Brodscholl J, Ogale S, McLean L. Primary Sjogren’s Syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes. 2009;7:46.CrossRefPubMedPubMedCentral Segal B, Bowman SJ, Fox PC, Vivino FB, Murukutla N, Brodscholl J, Ogale S, McLean L. Primary Sjogren’s Syndrome: health experiences and predictors of health quality among patients in the United States. Health Qual Life Outcomes. 2009;7:46.CrossRefPubMedPubMedCentral
37.
go back to reference Kessler RC, Akiskal HS, Ames M, Birnbaum H, Greenberg P, Hirschfeld RM, Jin R, Merikangas KR, Simon GE, Wang PS. Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. Am J Psychiatry. 2006;163:1561–8.CrossRefPubMedPubMedCentral Kessler RC, Akiskal HS, Ames M, Birnbaum H, Greenberg P, Hirschfeld RM, Jin R, Merikangas KR, Simon GE, Wang PS. Prevalence and effects of mood disorders on work performance in a nationally representative sample of U.S. workers. Am J Psychiatry. 2006;163:1561–8.CrossRefPubMedPubMedCentral
38.
go back to reference Knobloch LK, Delaney AL. Themes of relational uncertainty and interference from partners in depression. Health Commun. 2012;27:750–65.CrossRefPubMed Knobloch LK, Delaney AL. Themes of relational uncertainty and interference from partners in depression. Health Commun. 2012;27:750–65.CrossRefPubMed
39.
go back to reference Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370:851–8.CrossRefPubMed Moussavi S, Chatterji S, Verdes E, Tandon A, Patel V, Ustun B. Depression, chronic diseases, and decrements in health: results from the World Health Surveys. Lancet. 2007;370:851–8.CrossRefPubMed
40.
go back to reference Owsley C, McGwin GJ. Depression and the 25-item National Eye Institute Visual Function Questionnaire in older adults. Ophthalmology. 2004;111:2259–64.CrossRefPubMed Owsley C, McGwin GJ. Depression and the 25-item National Eye Institute Visual Function Questionnaire in older adults. Ophthalmology. 2004;111:2259–64.CrossRefPubMed
41.
go back to reference Vitale S, Goodman LA, Reed GF, Smith JA. Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjogren’s syndrome-related dry eye. Health Qual Life Outcomes. 2004;2:44.CrossRefPubMedPubMedCentral Vitale S, Goodman LA, Reed GF, Smith JA. Comparison of the NEI-VFQ and OSDI questionnaires in patients with Sjogren’s syndrome-related dry eye. Health Qual Life Outcomes. 2004;2:44.CrossRefPubMedPubMedCentral
Metadata
Title
Vision-related quality of life and psychological status in Chinese women with Sjogren’s syndrome dry eye: a case-control study
Authors
Yuqiu Zhang
Tong Lin
Alice Jiang
Naiqing Zhao
Lan Gong
Publication date
01-12-2016
Publisher
BioMed Central
Published in
BMC Women's Health / Issue 1/2016
Electronic ISSN: 1472-6874
DOI
https://doi.org/10.1186/s12905-016-0353-z

Other articles of this Issue 1/2016

BMC Women's Health 1/2016 Go to the issue